Jinyu Bio-technology Co., Ltd. Stock price

Equities

600201

CNE000000Y37

Pharmaceuticals

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
8.59 CNY +0.12% Intraday chart for Jinyu Bio-technology Co., Ltd. -3.48% -20.24%
Sales 2023 * 1.71B 237M Sales 2024 * 2.1B 291M Capitalization 9.34B 1.29B
Net income 2023 * 312M 43.18M Net income 2024 * 404M 55.91M EV / Sales 2023 * 4.72 x
Net cash position 2023 * 1.25B 173M Net cash position 2024 * 1.34B 185M EV / Sales 2024 * 3.81 x
P/E ratio 2023 *
30.9 x
P/E ratio 2024 *
23.9 x
Employees 1,618
Yield 2023 *
1.43%
Yield 2024 *
1.6%
Free-Float 80.2%
More Fundamentals * Assessed data
Dynamic Chart
Taihe Technologies' Chief Financial Officer Resigns MT
Jinyu Bio-Technology's Unit Ties Up With Shanghai Lanque Biomedicine for African Swine Fever Vaccine Development MT
Jinyu Bio-Technology Teams Up with RNA Cure to Develop mRNA Vaccine for African Swine Fever MT
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jinyu Bio-Technology's Unit Cattle Vaccine Passes Emergency Evaluation in China MT
Jinyu Bio-Technology Wins Nod to Market Veterinary Vaccine MT
Jinyu Bio-technology Co., Ltd.(XSSC:600201) added to S&P Global BMI Index CI
Jinyu Bio-technology Co., Ltd.(XSSC:600201) added to FTSE All-World Index CI
Jinyu Bio-Technology Registers Veterinary Vaccine For Sheep MT
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jinyu Bio-Technology Selling 800 Million Yuan Shares to Expand Animal Vaccine Production MT
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022. CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022. CI
Jinyu Bio-technology Co., Ltd.'s Equity Buyback announced on April 8, 2022, has closed with 33,001,600 shares, representing 2.97% for CNY 289.98 million. CI
More news
1 day+0.12%
1 week-3.48%
Current month-0.92%
1 month-2.94%
3 months-19.94%
6 months-9.58%
Current year-20.24%
More quotes
1 week
8.55
Extreme 8.55
9.05
1 month
8.32
Extreme 8.32
9.10
Current year
6.94
Extreme 6.94
10.93
1 year
6.94
Extreme 6.94
12.09
3 years
6.94
Extreme 6.94
22.10
5 years
6.94
Extreme 6.94
31.15
10 years
6.94
Extreme 6.94
31.15
More quotes
Managers TitleAgeSince
Director of Finance/CFO 38 21-04-30
President 41 -
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 56 22-05-30
Chairman 70 04-05-26
Director/Board Member 61 19-04-25
More insiders
Date Price Change Volume
24-03-28 8.59 +0.12% 9,504,595
24-03-27 8.58 -1.61% 9,955,104
24-03-26 8.72 +0.58% 9,039,100
24-03-25 8.67 -1.81% 10,722,710
24-03-22 8.83 -2.43% 12,081,620

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
JINYU BIO-TECHNOLOGY CO., LTD. formerly INNER MONGOLIA JINYU GROUP CO., LTD, is a China-based company, principally engaged in the research and development, manufacture and sales of veterinary biopharmaceuticals. The Company mainly provides veterinary vaccines. The Company is also engaged in textile processing business, and the provision of property leasing and management activities. The Company also provides energy products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
8.59 CNY
Average target price
9.475 CNY
Spread / Average Target
+10.30%
Consensus
  1. Stock
  2. Equities
  3. Stock Jinyu Bio-technology Co., Ltd. - Shanghai S.E.